DSS unit Impact Biomedical sets terms for downsized $6M IPO
Impact Biomedical (IBO), a subsidiary of DSS (DSS), has disclosed updated terms for a downsized $6M initial public offering. Read more here.
Source: seekingalpha.com
Impact Biomedical News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Impact Biomedical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Impact Biomedical Today - Breaking & Trending Today
Impact Biomedical, Inc. Announces U.S. Patent Allowance of
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is...
Source: globenewswire.com
DSS, Inc. Announces Filing of Registration Statement on
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE American: DSS) (
Source: globenewswire.com
DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical
NEW YORK, Oct. 23, 2023 -- DSS, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial...
Source: marketscreener.com
Impact Biomedical files for IPO
Impact Biomedical has filed for an initial public offering, according to a filing with the Securities and Exchange Commission. The provider of natural and…
Source: biztoc.com